MedTrace Logo

ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

NCT02935855 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2020-11-10

No results posted yet for this study

Summary

Diabetic and nondiabetic patients will be evaluated if they had a first diagnosis of non-valvular atrial fibrillation and in therapy with non-vitamin K oral anticoagulants and with vitamin K oral anticoagulants.

Conditions

Interventions

DRUG

Dabigatran

DRUG

Apixaban

DRUG

Rivaroxaban

DRUG

Edoxaban

DRUG

Warfarin

DRUG

Acenocumarole

Sponsors & Collaborators

  • University of Pavia

    lead OTHER

Principal Investigators

  • Giuseppe Derosa, MD, PhD, FESC · University of Pavia and IRCCS Policlinico San Matteo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2019-04-30
Completion
2019-09-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02935855 on ClinicalTrials.gov